Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Carcinoma, Non-Small-Cell Lung 15Lung Neoplasms 7Nasopharyngeal Carcinoma 6Colorectal Neoplasms 4Breast Neoplasms 3Uterine Cervical Neoplasms 2Melanoma 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Esophageal Neoplasms 2Stomach Neoplasms 1Sarcoma 1Recurrence 1Radiation Injuries 1Quality of Life 1Osteosarcoma 1Non-squamous Non-small Cell Lung Cancer 1Neuroblastoma 1Nasopharyngeal Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Brain Neoplasms 1Advanced Pancreatic Cancer 1Advanced Colorectal Cancer 1Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 5fludarabine 4N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 3Gemcitabine 3fludarabine phosphate 2endostar protein 2Melphalan 2Etoposide 2Doxorubicin 2Cisplatin 2Alemtuzumab 2thymoglobulin 1spartalizumab 1selinexor 1pembrolizumab 1Vindesine 1Vincristine 1Sensitivity and Specificity 1Rituximab 1Prednisone 1Prednisolone 1Methylprednisolone 1Interleukin-2 1Flavin-Adenine Dinucleotide 1Epirubicin 1Endostatins 1Drug Therapy 1Dexamethasone 1Cytarabine 1Clinical Protocols 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Lymphoma, T-Cell × endostar protein × Clear all
NCT01430013 2015-11-04

Trial of Endostar Combined With CHOPT for T Cell Lymphoma

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown
30 enrolled
Lymphoid

Lymphoma, T-Cell

NCT00974324 2010-09-15

PTCL

Fudan University

Phase 2 Unknown
15 enrolled
Lymphoid

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡